VRAX vs. LHDXQ, LHDX, NAVB, CDIO, SNPX, PHIO, OGEN, AVGR, NBSE, and IGAP
Should you be buying Virax Biolabs Group stock or one of its competitors? The main competitors of Virax Biolabs Group include Lucira Health (LHDXQ), Lucira Health (LHDX), Navidea Biopharmaceuticals (NAVB), Cardio Diagnostics (CDIO), Synaptogenix (SNPX), Phio Pharmaceuticals (PHIO), Oragenics (OGEN), Avinger (AVGR), NeuBase Therapeutics (NBSE), and Integrity Applications (IGAP). These companies are all part of the "medical" sector.
Virax Biolabs Group vs.
Virax Biolabs Group (NASDAQ:VRAX) and Lucira Health (NASDAQ:LHDXQ) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings, community ranking and profitability.
In the previous week, Virax Biolabs Group had 2 more articles in the media than Lucira Health. MarketBeat recorded 2 mentions for Virax Biolabs Group and 0 mentions for Lucira Health. Virax Biolabs Group's average media sentiment score of 0.00 equaled Lucira Health's average media sentiment score.
0.5% of Virax Biolabs Group shares are held by institutional investors. Comparatively, 57.0% of Lucira Health shares are held by institutional investors. 45.1% of Virax Biolabs Group shares are held by company insiders. Comparatively, 30.4% of Lucira Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Virax Biolabs Group has higher earnings, but lower revenue than Lucira Health.
Virax Biolabs Group and Lucira Health both received 0 outperform votes by MarketBeat users.
Virax Biolabs Group has a net margin of 0.00% compared to Lucira Health's net margin of -67.54%. Virax Biolabs Group's return on equity of 0.00% beat Lucira Health's return on equity.
Summary
Virax Biolabs Group beats Lucira Health on 7 of the 9 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding VRAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Virax Biolabs Group Competitors List
Related Companies and Tools